Climb Bio (CLYM) Other Non Operating Income (2020 - 2026)

Climb Bio (CLYM) has 7 years of Other Non Operating Income data on file, last reported at -$25000.0 in Q1 2026.

• Quarterly Other Non Operating Income rose 50.0% year-over-year to -$25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$266000.0 (down 923.08% YoY) and the FY2025 annual result came in at -$291000.0, down 3133.33% from the prior year.
• Other Non Operating Income advanced to -$25000.0 in Q1 2026, from -$46000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.8 million in Q4 2022 to a low of -$934000.0 in Q3 2022.
• A 5-year average of $351647.1 and a median of -$25000.0 in 2026 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1034.18% — and 2025, when it tumbled 8000.0%.
• Tracing CLYM's Other Non Operating Income over 5 years: stood at $1.8 million in 2022, then declined by 17.35% to $1.5 million in 2023, then sank by 101.76% to -$26000.0 in 2024, then slumped by 76.92% to -$46000.0 in 2025, then surged by 45.65% to -$25000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$25000.0 (Q1 2026), -$46000.0 (Q4 2025), and -$33000.0 (Q3 2025), per Business Quant data.